Lifestyle Delivery Systems Inc. (LDSYF) announces CSPA Group Inc. and LDS Scientific’s CannaStrips™ and Rèveur debut

0
1007

Lifestyle Delivery Systems Inc. announces CSPA Group Inc. and LDS Scientific’s CannaStrips™ and Rèveur debut

 Lifestyle Delivery Systems Inc. (LDS.CN), (LDSYF), (Frankfurt: LD6, WKN: A14XHT) (“LDS” or the “Company”) announces CSPA Group Inc. and LDS Scientific’s debut  of CannaStripsTM and the Rêveur luxury brand of cannabis products for the California market during the Indio, CAdesert festival weekends, which will take place on April 13-15April 20-22 and April 27-29, 2018.

The products will be available from local delivery services and information on the products will be available at the CannaStripsTM/Rêveur promotion suite during all of the April 2018 Indio, CA desert festivals at the Base Camp enclave poolside, where exclusive special promotional coupons will be available.

CSPA Group Inc. has been test marketing five new 10-mg formula versions of CannaStripsTM. The following versions were used in the test marketing:

  • 10 mg THC full spectrum strip with trace amounts of CBD and CBN;
  • 5 mg THC and 5 mg CBD 50/50 blend;
  • 8 mg CBD and 2 mg THC;
  • the sleep version with 8 mg CBD, 2 mg THC, melatonin and serotonin; and
  • 8 mg CBD 2 mg THCa, 10 mg curcumin with trace amounts of CBN and CBG.

The CEO of LDS, Brad Eckenweiler, commented, “These five versions represent the results of our market research combined with customer comments, requests and suggestions received over the past three months. The resulting products, we believe, represent the best combinations of ingredients to meet the demands of the current market given the regulatory guidelines.” The Company’s latest packaging and logo designs for CannaStripsTM and Rêveur will be posted on Reveurbrands.com, Cannastrips.com and LifestyleDeliverySystems.com, as early as on Tuesday, April 10, 2018.

About Base Camp

Base Camp is a “Pop-Up” camping resort taking place during all Indio, CA desert festival weekends in April 2018 (April 12-16April 19-23 & April 26-30)

www.welcometobasecamp.com

About Lifestyle Delivery Systems Inc.

Lifestyle Delivery Systems Inc. is a licensed, state-compliant vertically integrated cannabis-related company.  From our isogenic pollination nursery to our cutting edge, state-of-the-art production facility located in Southern California, LDS has become one of the most diverse, innovative and scientifically based cannabis companies throughout North America. The Company’s technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to smoking but also a new way to accurately meter the dosage and assure the purity of the product. From start to finish, the production process tests for quality and composition of all the ingredients used in each and every strip, resulting in a delivery system that is safe, consistent and effective.

On behalf of the board of directors of Lifestyle Delivery Systems Inc.

Brad Eckenweiler
CEO & Director

FOR MORE INFORMATION, PLEASE CONTACT:
investor.relations@lifestyledeliverysystem.com
1-866-347-5058

Cautionary Disclaimer Statement:

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Such factors include, among other things: risks and uncertainties relating to the Company’s limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970.  Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect.  Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.

LEAVE A REPLY

Please enter your comment!
Please enter your name here